SK Biopharmaceutical’s Epilepsy Drug Xcopri Now Available in South Korea, Cutting Monthly Medication Costs by Up to $200
AI 요약 정보
- SK Biopharmaceutical's Xcopri now available in South Korea
- Coverage could save former US patients up to $200 monthly
- Hospital access depends on each facility's adoption process
